1. Home
  2. MNKD vs CHCO Comparison

MNKD vs CHCO Comparison

Compare MNKD & CHCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MNKD
  • CHCO
  • Stock Information
  • Founded
  • MNKD 1991
  • CHCO 1957
  • Country
  • MNKD United States
  • CHCO United States
  • Employees
  • MNKD N/A
  • CHCO N/A
  • Industry
  • MNKD Biotechnology: Pharmaceutical Preparations
  • CHCO Major Banks
  • Sector
  • MNKD Health Care
  • CHCO Finance
  • Exchange
  • MNKD Nasdaq
  • CHCO Nasdaq
  • Market Cap
  • MNKD 1.5B
  • CHCO 1.7B
  • IPO Year
  • MNKD 2004
  • CHCO N/A
  • Fundamental
  • Price
  • MNKD $5.76
  • CHCO $117.19
  • Analyst Decision
  • MNKD Buy
  • CHCO Hold
  • Analyst Count
  • MNKD 6
  • CHCO 3
  • Target Price
  • MNKD $8.92
  • CHCO $118.00
  • AVG Volume (30 Days)
  • MNKD 1.7M
  • CHCO 45.1K
  • Earning Date
  • MNKD 02-26-2025
  • CHCO 01-23-2025
  • Dividend Yield
  • MNKD N/A
  • CHCO 2.64%
  • EPS Growth
  • MNKD N/A
  • CHCO 3.68
  • EPS
  • MNKD 0.08
  • CHCO 7.89
  • Revenue
  • MNKD $267,200,000.00
  • CHCO $291,751,000.00
  • Revenue This Year
  • MNKD $44.15
  • CHCO N/A
  • Revenue Next Year
  • MNKD $19.65
  • CHCO $2.39
  • P/E Ratio
  • MNKD $72.34
  • CHCO $14.99
  • Revenue Growth
  • MNKD 51.35
  • CHCO 1.79
  • 52 Week Low
  • MNKD $3.47
  • CHCO $97.50
  • 52 Week High
  • MNKD $7.63
  • CHCO $137.28
  • Technical
  • Relative Strength Index (RSI)
  • MNKD 48.03
  • CHCO 43.53
  • Support Level
  • MNKD $5.32
  • CHCO $117.04
  • Resistance Level
  • MNKD $5.65
  • CHCO $122.62
  • Average True Range (ATR)
  • MNKD 0.18
  • CHCO 2.63
  • MACD
  • MNKD 0.03
  • CHCO 0.03
  • Stochastic Oscillator
  • MNKD 81.48
  • CHCO 29.20

About MNKD MannKind Corporation

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.

About CHCO City Holding Company

City Holding Co is a financial holding company. It provides banking, trust and investment management, and other financial solutions through its network of banking offices located in the states of West Virginia, Virginia, southeastern Ohio, and Kentucky. It offers various products and services such as overdraft facilities, saving accounts, credit card and debit cards, loans for various purposes, investment advisory, securities brokerage, insurance, technology products, and others. These products and services are provided to commercial banking, consumer banking, mortgage banking, wealth management, and trust services.

Share on Social Networks: